Diabetes

Researchers uncover how diabetes impairs nerve regeneration and propose potential therapies to restore nerve repair and function.

New study shows low LDL cholesterol is associated with higher type 2 diabetes risk, regardless of statin therapy, suggesting biomarker potential.

A new meta-analysis finds that simple, low-cost text message interventions can improve short-term blood sugar control in adults with diabetes.

Gestational diabetes in pregnancy changes the gut microbiome of newborns, increasing bacteria linked to inflammation and potential long-term health risks.

A pilot study shows that yoga and walking for type 2 diabetes significantly improve blood glucose outcomes, especially when combined.

A study in young adults shows that ultra-processed foods increase the risk of prediabetes and insulin resistance. Limiting ultra-processed foods may help prevent type 2 diabetes.

New study reveals how lifestyle, goals, and convenience shape diabetes patients’ diet choices, guiding better patient-centred advice.

A U.S. study finds that lower-body fat protects against type 2 diabetes, while abdominal fat increases risk, especially among men.

A major review of nearly 60,000 cases shows new diabetes subgroups could transform diagnosis and treatment through more personalised care approaches.

Elevated autoantibodies against incretin hormones may indicate poorer outcomes in diabetes, highlighting potential for new prognostic biomarkers.

Diabetes and psoriasis together increase risk of all-cause and cancer mortality, according to a U.S. population study.

Nationwide study finds midlife and older adults with type 2 diabetes face a 50% higher risk of very late-onset schizophrenia.

Gene therapy delivering protective vascular endothelial growth factor C into kidney filters reduced early diabetic kidney damage.

Learn how carnosine and β-alanine may improve blood sugar and β-cell function in Type 2 diabetes and prediabetes.

Learn how high-dose metformin improves BMI, insulin needs, and LDL-C in adolescents with T1D.

New data suggests omega-3 supplements provide little to no benefit for diabetic polyneuropathy.

GLP-1RA use lowered cardiovascular, kidney, and mortality risks in patients with lupus and diabetes

Learn how low-dose ATG may preserve β-cell function in young people with recent-onset Type 1 diabetes.

Understand how GLP-1 receptor agonists may reduce fracture risk and improve bone density in Type 2 diabetes

Learn how tirzepatide treatment improves diet-related quality of life and satisfaction in Type 2 diabetes patients.

A global study covering 204 countries found that fewer than one in four people with diabetes achieved optimal glycaemic control, highlighting persistent gaps in diagnosis and treatment despite improvements since 2000.

Appropriate risk assessment before prescribing treatment, along with personalised management strategies, could help reduce the long-term burden of cardiometabolic diseases in this population.

Obstructive sleep apnoea (OSA) is a common yet frequently undiagnosed condition among people with Type 2 diabetes…

Find out how app-based messaging supports diabetes management and reduces cardiovascular risks in adults with poor control. Keep reading.

Learn how GLP-1 RAs may cut peptic ulcer risk in diabetes patients by nearly half.

Discover how HBV immunity is linked to lower diabetes risk, suggesting added value of hepatitis B vaccination.

Discover how tirzepatide aids weight loss and insulin reduction in Type 1 diabetes with no increase in hypoglycaemia.

Understand how women with Type 1 diabetes have greater cardiovascular risk than those with Type 2.

Total potato intake was positively associated with risk of developing Type 2 diabetes, but this effect was primarily driven by intake of French fries.

Discover how new AI can spot hidden diabetes risk earlier than ever before. Keep reading for the full story.

Learn how canagliflozin safely improves glycaemic control in children with Type 2 diabetes.

Melatonin may improve long-term blood sugar control in Type 2 diabetes, with no significant impact on fasting glucose.

Low thyroid hormone levels may increase gestational diabetes risk, with isolated hypothyroxinaemia showing the strongest association.

Understand how diabetes may raise bone density over time, but fracture risk remains.

Discover how new research found that glipizide carries higher cardiovascular risk than DPP4 inhibitors in Type 2 diabetes treatment.

Although the link between Type 2 diabetes and increased breast cancer risk is well established, the relationship between GDM and breast cancer has remained unclear.

Learn how TCM plus PDE5 inhibitors boosts erectile function in diabetes patients, with no extra side effects reported.

Discover how SGLT-2 inhibitors are linked with reduced risk of serious liver events in cirrhosis patients.

Dapagliflozin reverses myocardial fibrosis in HFpEF with diabetes, suggesting a disease-modifying effect.

Understand how magnesium supplementation modestly improves fasting glucose in Type 2 diabetes.

Learn how EGF and UMOD levels may predict diabetic kidney disease progression, offering new tools for clinical risk assessment.

Discover how low-dose vitamin D may help regulate blood sugar in people with Type 2 diabetes.

Understand how a combined therapy shows significant nerve and glucose improvements in diabetic neuropathy, without added safety risks.

Learn how tighter glucose control in diabetic pregnancies lowers risk for key complications.

Hyperbaric oxygen therapy ranks highest for healing diabetic foot ulcers but may raise amputation risk, new network meta-analysis reveals.

New analysis finds acupuncture improves key symptoms of type 2 diabetes, including blood sugar and cholesterol markers.

Cortisol-blocking treatment significantly improves blood sugar control and weight in people with hard-to-treat Type 2 diabetes.

CagriSema significantly reduced body weight and HbA1c in adults with Type 2 diabetes in new Phase 3 trial.

Discover how zimislecel enables insulin independence in patients with Type 1 diabetes, showing strong efficacy in early clinical data.

Understand how diabetes raises risk of infection and complications post-hysterectomy.

Learn how high TEWL after healing is linked to twice the risk of DFU recurrence.

Dapagliflozin shows promise for treating MASH, improving liver outcomes without worsening fibrosis in a major trial.

A new patient-led weight maintenance programme outperforms standard care, offering scalable, effective obesity management.

Dual burden of diabetes and hypertension more than doubles cardiovascular death risk, especially in women, study finds.

Discover how TENS nerve stimulation offers effective pain and sleep relief for diabetic neuropathy.

Delaying statins raises cardiovascular risk in diabetes; timely treatment is essential to improve patient outcomes.

Research confirms Type 2 diabetes greatly increases risks of death, severity, and ventilation need in COVID-19 cases.

Diabetes significantly raises the risk of delirium, but metformin and intranasal insulin may offer protective effects.

Discover how adult-onset type 1 diabetes is linked to higher death rates and cardiovascular events, especially post-40 diagnosis.

New model predicts diabetes risk and recommends personalised prevention, including lifestyle changes or metformin, for diverse populations.

Learn how GLP-1 receptor agonists show promise in reducing alcohol consumption and aiding weight loss in obesity treatment.

A recent study utilizing UK Biobank data has identified a significant rise in new-onset mental health disorders—specifically depression, anxiety, and alcohol use disorders—among adults with metabolic diseases such as hypertension, diabetes, and obesity in the aftermath of the COVID-19 pandemic.

AI safely matches senior doctors in hospital insulin dosing for T2D, easing clinical load without compromising care.

Semaglutide significantly improves liver inflammation and fibrosis in MASH patients, offering new hope for clinical management.

Low-energy diets are safe in pregnancy with gestational diabetes but show no clinical benefit in weight or birth weight.

Read about how vitamin supplementation does not significantly influence the development or progression of Type 1 diabetes.

Switching to tirzepatide yields greater HbA1c and weight reductions than escalating dulaglutide in Type 2 diabetes.

Elevated triglycerides in well-controlled gestational diabetes linked to increased pregnancy risks, suggesting lipid monitoring may be crucial.

Mind-body exercises show promising benefits for type 2 diabetes, improving blood sugar, weight, and heart health markers.

Higher eGDR linked with lower mortality and cardiovascular risk in diabetes, offering promise for clinical risk stratification.

Newer diabetes drugs linked to reduced risk of dementia in older adults, real-world data shows promising results.

Study links metformin use to increased diabetic neuropathy risk in dose-dependent fashion.

Understand how gestational diabetes is linked to ADHD symptoms in children.

Immunotherapy shows promise for improving glycaemic control in children with Type 1 diabetes.

Higher muscle strength may offset genetic risk of Type 2 diabetes, offering a new route for prevention.

Roux-en-Y gastric bypass outperforms sleeve gastrectomy and adjustable gastric banding, study finds.

Long-term ICS use in COPD is linked to increased risks of Type 2 diabetes, pneumonia, fractures, and more.

Oral semaglutide reduces cardiovascular events in type 2 diabetes, independent of SGLT2i therapy, with no safety concerns.

A study has demonstrated the feasibility of a mobile health-supported home-delivered physical activity programme for individuals recently diagnosed with Type 2 diabetes.

A recent study explored impact of hypertension and type 2 diabetes on kidney structure, revealing similar damage in both conditions.

Semaglutide use in diabetic patients linked to increased risk of NAION after two years of treatment.

New research shows that animal and total protein intake could reduce the risk of gestational diabetes during pregnancy.

A new predictive model helps personalise glucose-lowering therapy for type 2 diabetes, improving glycaemic control and reducing complications.

Poor sleep quality in geriatric type 2 diabetes patients is linked to worse glycaemic control and complications.

Research suggests that automated insulin delivery (AID) systems may play a significant role in enhancing glucose management.

Pioglitazone/metformin FDC with dapagliflozin may provide effective and safe management for Type 2 diabetes. Read more!

Short sleep and snoring linked to higher Type 2 diabetes risk in women with a history of gestational diabetes.

New research has investigated how a combination of dapagliflozin and moderate calorie restriction can cause remission in Type 2 diabetes

People with a genetic risk for type 2 diabetes may face a greater threat to heart health if they spend too much time watching TV, according to a new study.

New research has confirmed that automated insulin delivery (AID) systems are both safe and effective for older adults with Type 1 diabetes.

A high-protein vegan diet rich in mycoprotein improves glycaemic control in Type 2 diabetes, comparable to an omnivorous diet.

Inadequate sleep duration and persistent late sleep onset are associated with significant fluctuations in blood glucose levels according to a recent study.

New findings shed light on the brain’s role as a critical control centre in the development of obesity and Type 2 diabetes.

New research uncovers explanation for higher rates of Type 2 diabetes in Asian Indian populations.

People with Type 1 diabetes can achieve the same positive outcomes using advanced insulin technology when trained by their PCPs or through telehealth as they would by visiting a specialist in person according to new study.

A recent genetic study has provided new insights into how glucagon-like peptide-1 (GLP-1) receptor agonists aid weight loss.

A novel heparanase inhibitor preserves vascular integrity in diabetes, preventing microvascular complications in the eye and kidney.

Study shows that engaging in moderate to vigorous physical activity during leisure time is associated with a reduced risk of Type 2 diabetes.

Study has shed light on a potential pathway for combating insulin resistance.

Researchers have found that sulforaphane, a chemical compound found in broccoli sprouts, can significantly improve blood sugar levels in people with prediabetes.

A recent study has uncovered a worrying link between diabetes and the rapid emergence of antibiotic resistance.

SGLT-2is and GLP-1RAs linked to lower COPD exacerbation risk in T2D patients, study finds.

Mitochondria dysfunction has been found to be involved in the development of diabetes in newly published research.

Plant-based monounsaturated fats may lower Type 2 diabetes risk, while animal-derived sources are linked to higher risk.